ZA931491B - Novel cyclosporins - Google Patents

Novel cyclosporins

Info

Publication number
ZA931491B
ZA931491B ZA931491A ZA931491A ZA931491B ZA 931491 B ZA931491 B ZA 931491B ZA 931491 A ZA931491 A ZA 931491A ZA 931491 A ZA931491 A ZA 931491A ZA 931491 B ZA931491 B ZA 931491B
Authority
ZA
South Africa
Prior art keywords
cyclosporins
amino
novel cyclosporins
novel
2alkyl
Prior art date
Application number
ZA931491A
Other languages
English (en)
Inventor
Johann J Boelsterli
Marcel K Eberle
Reto Naef
Trevor G Payne
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA931491B publication Critical patent/ZA931491B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Gasification And Melting Of Waste (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA931491A 1992-03-02 1993-03-02 Novel cyclosporins ZA931491B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204466A GB9204466D0 (en) 1992-03-02 1992-03-02 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
ZA931491B true ZA931491B (en) 1994-09-02

Family

ID=10711333

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931491A ZA931491B (en) 1992-03-02 1993-03-02 Novel cyclosporins

Country Status (26)

Country Link
US (1) US5643870A (sk)
EP (1) EP0577544B1 (sk)
JP (1) JP3382656B2 (sk)
KR (1) KR100256988B1 (sk)
CN (1) CN1037104C (sk)
AT (1) ATE146484T1 (sk)
AU (1) AU667072B2 (sk)
CA (1) CA2090634C (sk)
CZ (1) CZ285421B6 (sk)
DE (1) DE69306670T2 (sk)
DK (1) DK0577544T3 (sk)
ES (1) ES2096262T3 (sk)
FI (1) FI111729B (sk)
GB (1) GB9204466D0 (sk)
GR (1) GR3022539T3 (sk)
HU (1) HU214028B (sk)
IL (1) IL104891A (sk)
MX (1) MX9301129A (sk)
MY (1) MY106921A (sk)
NO (1) NO310685B1 (sk)
NZ (1) NZ247031A (sk)
PL (1) PL174816B1 (sk)
RU (1) RU2131883C1 (sk)
SK (1) SK279529B6 (sk)
TW (1) TW264472B (sk)
ZA (1) ZA931491B (sk)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639852A (en) * 1994-09-01 1997-06-17 Wisconsin Alumni Research Foundation Immunostimulatory agents
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'-脱氧-3'-氧代-MeBmt]'环孢菌素制备方法
ZA9711732B (en) 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
DE69832984T2 (de) 1997-10-08 2006-09-21 Isotechnika, Inc., Edmonton DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US6784156B2 (en) 2001-03-05 2004-08-31 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of respiratory diseases
US6809077B2 (en) * 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
US20030087813A1 (en) * 2001-10-12 2003-05-08 Or Yat Sun Cyclosporin analogs for the treatment of lung diseases
PL210795B1 (pl) 2001-10-19 2012-03-30 Isotechnika Inc Sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (E), sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (Z), sposób stereoselektywnej syntezy izomeru (E) ISATX247, sposób stereoselektywnej syntezy izomeru (Z) ISATX247 i sposób wytwarzania mieszaniny izomerów ISATX247
US7012065B2 (en) * 2003-02-07 2006-03-14 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of immune disorders
JP2006524232A (ja) * 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
US20040266669A1 (en) * 2003-06-20 2004-12-30 Wu Frank X. H. Cyclosporin derivatives for the treatment of immune disorders
JP2006014722A (ja) * 2004-06-02 2006-01-19 Keio Gijuku 遺伝子マーカー及びその利用
WO2006039163A2 (en) * 2004-09-29 2006-04-13 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
WO2006039164A2 (en) * 2004-09-29 2006-04-13 Amr Technology, Inc. Novel cyclosporin analogues and their pharmaceutical uses
WO2006041631A2 (en) * 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US7696167B2 (en) * 2004-11-22 2010-04-13 Astellas Pharma Inc. Cyclic peptide compound
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
CA3014633C (en) 2007-10-08 2022-05-17 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
EP2307446A4 (en) * 2008-07-30 2012-11-07 Isotechnika Pharma Inc NON-IMMUNOSUPPRESSIVE CYCLOSPORINE ANALOGOUS MOLECULES
AU2010259184B2 (en) 2009-06-09 2015-08-13 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
US20130267460A1 (en) * 2010-09-16 2013-10-10 The Johns Hopkins University Methods of Inhibiting Alphavirus Replication and Treating Alphavirus Infection
BR112013014890B1 (pt) 2010-12-15 2023-10-24 Contravir Pharmaceuticals, Inc Composto análogo de moléculas pertencentes à família ciclosporina, composição farmacêutica compreendendo o mesmo, uso terapêutico ou profilático do referido composto e processos para a preparação dos mesmos
CN105076117B (zh) * 2014-10-31 2017-08-25 北京林业大学 一种种子抗老化剂及其制备方法
KR20170000243U (ko) 2015-07-09 2017-01-18 (주)하나피앤씨 배관연결용 플랜지 기구
US9981041B2 (en) * 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4764503A (en) * 1986-11-19 1988-08-16 Sandoz Ltd. Novel cyclosporins
EP0283801A3 (en) * 1987-03-27 1990-05-30 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
JPH04502328A (ja) * 1988-12-05 1992-04-23 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク シクロスポリンaの新規誘導体、それに対する抗体及びその使用
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
SK278808B6 (sk) * 1990-11-02 1998-03-04 Novartis Ag Cyklosporíny, ich použitie pri príprave liečiva na

Also Published As

Publication number Publication date
NO930738D0 (no) 1993-03-01
HU9300418D0 (en) 1993-05-28
NZ247031A (en) 1995-05-26
FI930912A (fi) 1993-09-03
AU3387293A (en) 1993-09-09
CZ30393A3 (en) 1994-02-16
GB9204466D0 (en) 1992-04-15
PL297902A1 (en) 1993-09-06
DE69306670D1 (de) 1997-01-30
IL104891A (en) 1997-04-15
US5643870A (en) 1997-07-01
MX9301129A (es) 1994-07-29
GR3022539T3 (en) 1997-05-31
KR930019692A (ko) 1993-10-18
CA2090634C (en) 2005-12-13
KR100256988B1 (ko) 2000-05-15
MY106921A (en) 1995-08-30
CA2090634A1 (en) 1993-09-03
CN1076453A (zh) 1993-09-22
PL174816B1 (pl) 1998-09-30
HU214028B (en) 1997-12-29
FI111729B (fi) 2003-09-15
JPH07252296A (ja) 1995-10-03
JP3382656B2 (ja) 2003-03-04
AU667072B2 (en) 1996-03-07
NO310685B1 (no) 2001-08-13
TW264472B (sk) 1995-12-01
SK279529B6 (sk) 1998-12-02
RU2131883C1 (ru) 1999-06-20
SK14093A3 (en) 1993-10-06
DE69306670T2 (de) 1997-07-03
ATE146484T1 (de) 1997-01-15
EP0577544B1 (en) 1996-12-18
DK0577544T3 (da) 1997-04-01
CZ285421B6 (cs) 1999-08-11
FI930912A0 (fi) 1993-03-01
EP0577544A1 (en) 1994-01-05
ES2096262T3 (es) 1997-03-01
IL104891A0 (en) 1993-07-08
NO930738L (no) 1993-09-03
CN1037104C (zh) 1998-01-21
HUT64567A (en) 1994-01-28

Similar Documents

Publication Publication Date Title
TW264472B (sk)
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
CA2135575A1 (fr) Composition cosmetique contenant en tant qu'agent reducteur un n-mercapto-alkyl alcanediamide ou l'un de ses sels cosmetiquement acceptable
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
ZA901743B (en) Use of phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis,inflammation and as immunosuppressants
ZA937112B (en) 17-aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstaniene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions contning same
EP0556912A3 (en) Rapid plasma hydrogenation process for polysilicon mosfet's
GB9305718D0 (en) Medicaments
HUT57178A (en) Process for producing new retinoids and paharmaceutical compositions comprising such active ingredient
HK1012847A1 (en) Levobupivacaine and its use as an anaesthetic in pregnant women
MX9505078A (es) Procedimientos para la preparacion de halogenodifluoroacetatos de alquilo.
GR3015132T3 (en) Novel ureas and thioureas, preparation thereof and application in therapy.
ZA942686B (en) Active compound from a sponge
GR3017335T3 (en) Oligophosphates with antiviral activity.
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
ES2124162A1 (es) Un nuevo procedimiento para preparar compuestos farmaceuticamente activos.
Palani Professor Dr. N. Subbu Reddiar's contributions for the enrichment of Tamil
MY111222A (en) N-[[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]-n-methyl-amino]-2-benzothiazolols as class iii antiarrhythmic agents.
IT1256925B (it) Impiego di frammenti o/e di derivati della timosina alfa 1.
BG101119A (en) Analgesic composition
ITTE930001A1 (it) Procedimento per l'arricchimento del tenore in zeoliti di sottoprodotti delle cave di blocchetti di "tufo litoide"
GEU2002891Y (en) Imnadze Ointment
MY128749A (en) Fungicidal mixtures